The Efficacy of Regional Scalp Block in Craniotomy
Status:
COMPLETED
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
The objective of this clinical trial is to evaluate the role of scalp nerve block in craniotomy. The primary questions it seeks to answer are: What are the efficacy and safety profiles of scalp nerve block in craniotomy? The anesthesia protocol and monitoring were standardized for all participants. Participants were divided into two groups: the scalp nerve block group and the general anesthesia group. General anesthesia was induced using fentanyl (1-2 mcg/kg), propofol (1-2 mg/kg), and rocuronium (0.6 mg/kg). In the scalp nerve block group, a nerve block was administered using 0.5% ropivacaine.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Universitas Airlangga
Collaborators:
Dr. Soetomo Hospital, Surabaya Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia
Treatments:
Analgesics, Opioid Anesthesia, General Fentanyl Nerve Block Propofol Rocuronium Ropivacaine